These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20493190)

  • 1. Insulin-degrading enzyme antagonizes insulin-dependent tissue growth and Abeta-induced neurotoxicity in Drosophila.
    Tsuda M; Kobayashi T; Matsuo T; Aigaki T
    FEBS Lett; 2010 Jul; 584(13):2916-20. PubMed ID: 20493190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
    Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
    Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.
    Du J; Zhang L; Liu S; Zhang C; Huang X; Li J; Zhao N; Wang Z
    Biochem Biophys Res Commun; 2009 Jun; 383(4):485-90. PubMed ID: 19383491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
    Blomqvist ME; Chalmers K; Andreasen N; Bogdanovic N; Wilcock GK; Cairns NJ; Feuk L; Brookes AJ; Love S; Blennow K; Kehoe PG; Prince JA
    Neurobiol Aging; 2005 Jun; 26(6):795-802. PubMed ID: 15718037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
    Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
    Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
    Vepsäläinen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H
    Neurosci Lett; 2008 Jun; 438(2):216-20. PubMed ID: 18455870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons.
    Du J; Chang J; Guo S; Zhang Q; Wang Z
    Neurosci Lett; 2009 Oct; 464(2):140-5. PubMed ID: 19616072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease.
    Zhao Z; Xiang Z; Haroutunian V; Buxbaum JD; Stetka B; Pasinetti GM
    Neurobiol Aging; 2007 Jun; 28(6):824-30. PubMed ID: 16769157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of interactions of Alzheimer amyloid beta peptides (Abeta40 and Abeta42) with insulin degrading enzyme: a molecular dynamics study.
    Bora RP; Prabhakar R
    Biochemistry; 2010 May; 49(18):3947-56. PubMed ID: 20380468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter polymorphisms which modulate insulin degrading enzyme expression may increase susceptibility to Alzheimer's disease.
    Zuo X; Jia J
    Brain Res; 2009 Jan; 1249():1-8. PubMed ID: 18996360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of insulin-degrading enzyme by presenilin 1 V97L mutant potentially underlies increased levels of amyloid beta 42.
    Qin W; Jia J
    Eur J Neurosci; 2008 May; 27(9):2425-32. PubMed ID: 18445230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral proteolysis of amiloid-b peptide: relevance of insulin-degrading enzyme in Alzheimer's disease].
    Leal MC; Fernandez Gamba A; Morelli L; Castaño EM
    Medicina (B Aires); 2009; 69(4):466-72. PubMed ID: 19770104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
    Qiu WQ; Folstein MF
    Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of Alzheimer's Abeta peptide: the many roads to perdition.
    Tanzi RE; Moir RD; Wagner SL
    Neuron; 2004 Sep; 43(5):605-8. PubMed ID: 15339642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention.
    Eckman EA; Eckman CB
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1101-5. PubMed ID: 16246055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
    Lynch JA; George AM; Eisenhauer PB; Conn K; Gao W; Carreras I; Wells JM; McKee A; Ullman MD; Fine RE
    J Neurosci Res; 2006 May; 83(7):1262-70. PubMed ID: 16511862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroscience. Insulin insults may spur Alzheimer's disease.
    Taubes G
    Science; 2003 Jul; 301(5629):40-1. PubMed ID: 12843374
    [No Abstract]   [Full Text] [Related]  

  • 20. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.